BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12700646)

  • 1. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region.
    Coultas L; Pellegrini M; Visvader JE; Lindeman GJ; Chen L; Adams JM; Huang DC; Strasser A
    Cell Death Differ; 2003 Feb; 10(2):185-92. PubMed ID: 12700646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A putative role for human BFK in DNA damage-induced apoptosis.
    Ozören N; Inohara N; Núñez G
    Biotechnol J; 2009 Jul; 4(7):1046-54. PubMed ID: 19557800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells.
    Liu Z; Lu H; Jiang Z; Pastuszyn A; Hu CA
    Mol Cancer Res; 2005 Jan; 3(1):21-31. PubMed ID: 15671246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomics: the evolutionary history of the Bcl-2 family.
    Lanave C; Santamaria M; Saccone C
    Gene; 2004 May; 333():71-9. PubMed ID: 15177682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain.
    Hossini AM; Geilen CC; Fecker LF; Daniel PT; Eberle J
    Oncogene; 2006 Apr; 25(15):2160-9. PubMed ID: 16288206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
    Yin XM; Oltvai ZN; Korsmeyer SJ
    Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
    Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
    Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of core structural residues in the sequentially diverse and structurally homologous Bcl-2 family of proteins.
    Lama D; Sankararamakrishnan R
    Biochemistry; 2010 Mar; 49(11):2574-84. PubMed ID: 20141168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family.
    Scorilas A; Kyriakopoulou L; Yousef GM; Ashworth LK; Kwamie A; Diamandis EP
    Genomics; 2001 Mar; 72(2):217-21. PubMed ID: 11401436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for crucial electrostatic interactions between Bcl-2 homology domains BH3 and BH4 in the anti-apoptotic Nr-13 protein.
    Lalle P; Aouacheria A; Dumont-Miscopein A; Jambon M; Venet S; Bobichon H; Colas P; Deléage G; Geourjon C; Gillet G
    Biochem J; 2002 Nov; 368(Pt 1):213-21. PubMed ID: 12133006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
    Schmitt E; Paquet C; Beauchemin M; Bertrand R
    Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins.
    Gurudutta GU; Verma YK; Singh VK; Gupta P; Raj HG; Sharma RK; Chandra R
    FEBS Lett; 2005 Jul; 579(17):3503-7. PubMed ID: 15949801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induction by Bcl-2 proteins independent of the BH3 domain.
    Hossini AM; Eberle J
    Biochem Pharmacol; 2008 Dec; 76(11):1612-9. PubMed ID: 18778689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
    García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
    Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
    Zha H; Aimé-Sempé C; Sato T; Reed JC
    J Biol Chem; 1996 Mar; 271(13):7440-4. PubMed ID: 8631771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
    Raghav PK; Verma YK; Gangenahalli GU
    Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iridovirus Bcl-2 protein inhibits apoptosis in the early stage of viral infection.
    Lin PW; Huang YJ; John JA; Chang YN; Yuan CH; Chen WY; Yeh CH; Shen ST; Lin FP; Tsui WH; Chang CY
    Apoptosis; 2008 Jan; 13(1):165-76. PubMed ID: 17955372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of the subcellular localization of the Drosophila Bcl-2 homologues DEBCL and BUFFY.
    Doumanis J; Dorstyn L; Kumar S
    Cell Death Differ; 2007 May; 14(5):907-15. PubMed ID: 17205077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and biochemical properties of soluble recombinant human Bax.
    Lewis S; Bethell SS; Patel S; Martinou JC; Antonsson B
    Protein Expr Purif; 1998 Jun; 13(1):120-6. PubMed ID: 9631524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.
    Mei Y; Du W; Yang Y; Wu M
    Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.